top of page
Julian-Howell.png

Julian Howell

CHIEF EXECUTIVE OFFICER

Julian is CEO at LUNAC. Prior to joining LUNAC, Julian held several senior leadership positions in biopharmaceutical development, most recently as Chief Medical Officer at ReNeuron where he managed and provided direction for the company’s work in developing stem cell therapies targeting areas of significant unmet need. Previously, he had served as Group Medical Director at Shield Therapeutics, leading products through all stages of clinical development to EU and US approval. As Head of Clinical Development and Medical Affairs at ProStakan his teams contributed to the licencing of multiple new products. Julian also held clinical development positions at Roche and Smithkline Beecham. Throughout his career, Julian has been involved in multiple new medicines approvals in the US and EU and has led development teams across a range of therapy areas. Julian qualified as a surgeon in London, working in the UK’s NHS before completing an MBA at Cranfield University. He is also a Fellow of the Faculty of Pharmaceutical Medicine.

bottom of page